Cited by 177Inflammatory mediators and NSAID effectsEicosanoids and Hypertension PharmacologyMenstrual Health and Disorders

Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium

Open access
Sales, K J, Jabbour, H N·2003·Reproduction

Abstract

Prostaglandins are bioactive lipids produced from arachidonic acid by cyclooxygenase (COX) enzymes and specific terminal prostanoid synthase enzymes. After biosynthesis, prostaglandins exert an autocrine-paracrine function by coupling to specific prostanoid G protein-coupled receptors to activate intracellular signalling and gene transcription. For many years, prostaglandins have been recognized as key molecules in reproductive biology by regulating ovulation, endometrial physiology and proliferation of endometrial glands and menstruation. More recently, a role for COX enzymes and prostaglandins has been ascertained in reproductive tract pathology, including carcinomas, menorrhagia, dysmenorrhoea and endometriosis. Although the mechanism by which prostaglandins modulate these pathologies is still unclear, a large body of evidence supports a role for COX enzymes, prostaglandins and prostaglandin receptor signalling pathways in angiogenesis, apoptosis and proliferation, tissue invasion and metastases and immunosuppression. Here, an overview is provided of some of the findings from these studies with specific emphasis on the role of COX enzymes, prostaglandin E(2) and F2α in disorders of endometrial proliferation and menstruation in non-pregnant women.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/rep.0.1260559

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In cancers of the breast, endometrium and ovary, CYP19A1 expression is primarily regulated by increased activity of the I.3/II promoter region, which can be upregulated by prostaglandins such as PGE2.

    “Notably, Bulun and colleagues have found that in cancers of breast, endometrium and ovary, expression is primarily regulated by increased activity of the I.3/II promoter region, which can be upregulated by prostaglandins such as PGE2, providing a link between the overexpression of PGs that has been reported to occur in EC [79] and intracrine oestrogen biosynthesis [80].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 80

  1. Adelantado JM Lopez Bernal A Turnbull AC Topographical distribution of prostaglandin E receptors in human myometrium British Journal of Obstetrics and Gynaecology 1988a 95 348 353 2898257
  2. Adelantado JM Rees MC Lopez Bernal A Turnbull AC Increased uterine prostaglandin E receptors in menorrhagic women British Journal of Obstetrics and Gynaecology 1988b 95 162 165 2894838
  3. Aplin AE Howe A Alahari SK Juliano RL Signal transduction and signal modulation by cell adhesion receptors the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins Pharmacology Reviews 1998 50 197 263 9647866
  4. Ashby B Co-expression of prostaglandin receptors with opposite effects: a model for homeostatic control of autocrine and paracrine signaling Biochemical Pharmacology 1998 55 239 246 9484788
  5. Bhattacharya M Peri KG Almazan G Ribeiro-da-Silva A Shichi H Durocher Y Abramovitz M Hou X Varma DR Chemtob S Nuclear localization of prostaglandin E2 receptors Proceedings National Academy of Sciences USA 1998 95 15 792 15 797 PMC28123 9861049
  6. Bhattacharya M Peri K Ribeiro-da-Silva A Almazan G Shichi H Hou X Varma DR Chemtob S Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope Journal of Biological Chemistry 1999 274 15 719 15 724 10336471
  7. Bulun SE Zeitoun KM Takayama K Sasano H Estrogen biosynthesis in endometriosis molecular basis and clinical relevance Journal of Molecular Endocrinology 2000a 25 35 42 10915216
  8. Bulun SE Zeitoun KM Takayama K Sasano H Molecular basis for treating endometriosis with aromatase inhibitors Human Reproduction Update 2000b 6 413 418 11045871
  9. Bulun SE Gurates B Fang Z Tamura M Sebastian S Zhou J Amin S Yang S Mechanisms of excessive estrogen formation in endometriosis Journal of Reproductive Immunology 2002a 55 21 33 12062819
  10. Bulun SE Yang S Fang Z Gurates B Tamura M Sebastian S Estrogen production and metabolism in endometriosis Annals of the New York Academy of Science 2002b 955 75 85 11949967
  11. Buttram VC Jr Reiter RC Uterine leiomyomata etiology, symptomatology, and management Fertility and Sterility 1981 36 433 445 7026295
  12. Canis M Bouquet De Jolinieres J Wattiez A Pouly JL Mage G Manhes H Bruhat MA Classification of endometriosis Bailliere’s Clinical Obstetrics and Gynaecology 1993 7 759 774 8131314
  13. Chan BS Satriano JA Pucci M Schuster VL Mechanism of prostaglandin E2 transport across the plasma membrane of HeLa cells and Xenopus oocytes expressing the prostaglandin transporter ‘PGT’ Journal of Biological Chemistry 1998 273 6689 6697 9506966
  14. Chandrasekharan NV Dai H Roos KL Evanson NK Tomsik J Elton TS Simmons DL COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression Proceedings National Academy of Sciences USA 2002 99 13 926 13 931 PMC129799 12242329
  15. Chiarugi V Magnelli L Gallo O Cox-2, iNOS and p53 as play-makers of tumor angiogenesis International Journal of Molecular Medicine 1998 2 715 719 9850741
  16. Christofori G Semb H The role of the cell-adhesion molecule E-cadherin as a tumour- suppressor gene Trends in Biochemical Sciences 1999 24 73 76 10098402
  17. Chulada PC Thompson MB Mahler JF Doyle CM Gaul BW Lee C Tiano HF Morham SG Smithies O Langenbach R Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice Cancer Research 2000 60 4705 4708 10987272
  18. Clancy R Varenika B Huang W Ballou L Attur M Amin AR Abramson SB Nitric oxide synthase/COX cross-talk nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production Journal of Immunology 2000 165 1582 1587 10903767
  19. Coleman RA Smith WL Narumiya S International Union of Pharmacology classification of prostanoid receptors properties, distribution, and structure of the receptors and their subtypes Pharmacology Reviews 1994 46 205 229 7938166
  20. Daniels SE Talwalker S Torri S Snabes MC Recker DP Verburg KM Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea Obstetrics and Gynecology 2002 100 350 358 12151162
  21. DeWitt DL Prostaglandin endoperoxide synthase regulation of enzyme expression Biochimica et Biophysica Acta 1991 1083 121 134 1903657
  22. Dinchuk JE Car BD Focht RJ Johnston JJ Jaffee BD Covington MB Contel NR Eng VM Collins RJ Czerniak PM Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II Nature 1995 378 406 409 7477380
  23. DuBois RN Shao J Tsujii M Sheng H Beauchamp RD G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2 Cancer Research 1996 56 733 737 8631005
  24. Erickson BA Longo WE Panesar N Mazuski JE Kaminski DL The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis Journal of Surgery Research 1999 81 101 107 9889067
  25. Ferrandina G Legge F Ranelletti FO Zannoni GF Maggiano N Evangelisti A Mancuso S Scambia G Lauriola L Cyclooxygenase-2 expression in endometrial carcinoma correlation with clinicopathologic parameters and clinical outcome Cancer 2002 95 801 807 12209724
  26. Forman BM Chen J Evans RM Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta Proceedings National Academy of Sciences USA 1997 94 4312 4317 PMC20719 9113986
  27. Fraser IS Prostaglandins, prostaglandin inhibitors and their roles in gynaecological disorders Bailliere’s Clinical Obstetrics and Gynaecology 1992 6 829 857 1478000
  28. Fujino H Srinivasan D Regan JW Cellular conditioning and activation of beta-catenin signalling by the FPB prostanoid receptor Journal of Biological Chemistry 2002 277 48 786 48 795 12368277
  29. Gross GA Imamura T Luedke C Vogt SK Olson LM Nelson DM Sadovsky Y Muglia LJ Opposing actions of prostaglandins and oxytocin determine the onset of murine labor Proceedings National Academy of Sciences USA 1998 95 11 875 11 879 PMC21733 9751758
  30. Halme J White C Kauma S Estes J Haskill S Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro Journal of Clinical Endocrinology and Metabolism 1988 66 1044 1049 3360897
  31. Haney AF Endometriosis-associated infertility Bailliere’s Clinical Obstetrics and Gynaecology 1993 7 791 812 8131316
  32. Haynes PJ Hodgson H Anderson AB Turnbull AC Measurement of menstrual blood loss in patients complaining of menorrhagia British Journal of Obstetrics and Gynaecology 1977 84 763 768 921913
  33. Hizaki H Segi E Sugimoto Y Hirose M Saji T Ushikubi F Matsuoka T Noda Y Tanaka T Yoshida N Narumiya S Ichikawa A Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2) Proceedings National Academy of Sciences USA 1999 96 10 501 10 506 PMC17918 10468638
  34. Hofmann GE Rao CV Barrows GH Sanfilippo JS Topography of human uterine prostaglandin E and F2 alpha receptors and their profiles during pathological states Journal of Clinical Endocrinology and Metabolism 1983 57 360 366 6134747
  35. Huang JC Liu DY Yadollahi S Wu KK Dawood MY Interleukin-1 beta induces cyclooxygenase-2 gene expression in cultured endometrial stromal cells Journal of Clinical Endocrinology and Metabolism 1998 83 538 541 9467571
  36. Jabbour HN Milne SA Williams ARW Anderson RA Boddy SC Expression of COX-2 and PGE synthase and synthesis of PGE2 in endometrial adenocarcinoma a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors British Journal of Cancer 2001 85 1023 1031 11592775
  37. Kelly RW Immunosuppressive mechanisms in semen implications for contraception Human Reproduction 1995 10 1686 1693 8582962
  38. Kennedy CR Zhang Y Brandon S Guan Y Coffee K Funk CD Magnuson MA Oates JA Breyer MD Breyer RM Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor Nature Medicine 1999 5 217 220 9930871
  39. Kulkarni S Rader JS Zhang F Liapis H Koki AT Masferrer JL Subbaramaiah K Dannenberg AJ Cyclooxygenase-2 is overexpressed in human cervical cancer Clinical Cancer Research 2001 7 429 434 11234900
  40. Langenbach R Morham SG Tiano HF Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration Cell 1995 83 483 492 8521478
  41. Langenbach R Loftin CD Lee C Tiano H Cyclooxygenase-deficient mice: a summary of their characteristics and susceptibilities to inflammation and carcinogenesis Annals of the New York Academy of Sciences 1999b 889 52 61 10668482
  42. Lim H Paria BC Das SK Dinchuk JE Langenbach R Trzaskos JM Dey SK Multiple female reproductive failures in cyclooxygenase 2-deficient mice Cell 1997 91 197 208 9346237
  43. Lundstrom V Green K Endogenous levels of prostaglandin F2alpha and its main metabolites in plasma and endometrium of normal and dysmenorrheic women American Journal of Obstetrics and Gynecology 1978 130 640 646 637076
  44. Makarainen L Ylikorkala O Primary and myoma-associated menorrhagia role of prostaglandins and effects of ibuprofen British Journal of Obstetrics and Gynaecology 1986 93 974 978 3533137
  45. Maldve RE Kim Y Muga SJ Fischer SM Prostaglandin E(2) regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors Journal of Lipid Research 2000 41 873 881 10828079
  46. Marnett LJ Aspirin and the potential role of prostaglandins in colon cancer Cancer Research 1992 52 5575 5589 1394181
  47. Mayer B Johnson JP Leitl F Jauch KW Heiss MM Schildberg FW Birchmeier W Funke I E-cadherin expression in primary and metastatic gastric cancer down regulation correlates with cellular dedifferentiation and glandular disintegration Cancer Research 1993 53 1690 1695 8453643
  48. Milne SA Jabbour HN Prostaglandin (PG) F(2alpha) receptor expression and signaling in human endometrium role of PGF(2alpha) in epithelial cell proliferation Journal of Clinical Endocrinology and Metabolism 2003 88 1825 1832 12679480
  49. Morita I Distinct functions of COX-1 and COX-2 Prostaglandins and Other Lipid Mediators 2002 68-69 165 175 12432916
  50. Narumiya S FitzGerald GA Genetic and pharmacological analysis of prostanoid receptor function Journal of Clinical Investigation 2001 108 25 30 11435452 PMC209349
  51. Narumiya S Sugimoto Y Ushikubi F Prostanoid receptors structures, properties, and functions Physiology Reviews 1999 79 1193 1226 10508233
  52. Ota H Igarashi S Sasaki M Tanaka T Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis Human Reproduction 2001 16 561 566 11228229
  53. Perchick GB Jabbour HN COX-2 overexpression inhibits cathepsin D-mediated cleavage of plasminogen to the potent anti-angiogenic factor angiostatin Endocrinology in press 12970159
  54. Prentice A O’Brien S Health burden of menstrual disorders Disorders of the Menstrual Cycle 2000 13 23 ACOG Press London
  55. Rees MC Heavy, painful periods Bailliere’s Clinical Obstetrics and Gynaecology 1989 3 341 356 2692924
  56. Rees MC Turnbull AC Menstrual disorders - an overview Bailliere’s Clinical Obstetrics and Gynaecology 1989 3 217 226 2692918
  57. Rees MC Anderson AB Demers LM Turnbull AC Endometrial and myometrial prostaglandin release during the menstrual cycle in relation to menstrual blood loss Journal of Clinical Endocrinology and Metabolism 1984a 58 813 818 6707186
  58. Rees MC Demers LM Anderson AB Turnbull AC A functional study of platelets in menstrual fluid British Journal of Obstetrics and Gynaecology 1984b 91 667 672 6430339
  59. Rees MC Canete-Soler R Lopez Bernal A Turnbull AC Effect of fenamates on prostaglandin E receptor binding Lancet 1988 2 541 542 2900923
  60. Ryu HS Chang KH Yang HW Kim MS Kwon HC Oh KS High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion Gynecologic Oncology 2000 76 320 325 10684704
  61. Sales KJ Katz AA Davis M Hinz S Soeters RP Hofmeyr MD Millar RP Jabbour HN Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are upregulated in carcinomas of the cervix a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors Journal of Clinical Endocrinology and Metabolism 2001 86 2243 2249 11344234 PMC2694306
  62. Sales KJ Katz AA Howard B Soeters RP Millar RP Jabbour HN Cyclooxygenase-1 is upregulated in cervical carcinomas autocrine/paracrine regulation of cyclooxygenase-2, PGE receptors and angiogenic factors by cyclooxygenase-1 Cancer Research 2002a 62 424 432 11809691 PMC2694304
  63. Sales KJ Katz AA Millar RP Jabbour HN Seminal plasma activates cyclooxygenase-2 and prostaglandin E(2) receptor expression and signalling in cervical adenocarcinoma cells Molecular Human Reproduction 2002b 8 1065 1070 12468638 PMC2694307
  64. Samaha HS Kelloff GJ Steele V Rao CV Reddy BS Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate and 6-phenylhexyl isothyocyanate apoptotic index as a biomarker in colon cancer chemoprevention and promotion Cancer Research 1997 57 1301 1305 9102217
  65. Seno H Oshima M Ishikawa T Oshima H Takaku K Chiba T Narumiya S Taketo MM Cyclooxygenase-2 and prostaglandin E2 receptor EP2-dependent angiogenesis in APC delta 716 mouse intestinal polyps Cancer Research 2002 62 506 511 11809702
  66. Sheng H Shao J Washington MK DuBois RN Prostaglandin E2 increases growth and motility of colorectal carcinoma cells Journal of Biological Chemistry 2001 276 18 075 18 081 11278548
  67. Smith SK Abel MH Kelly RW Baird DT Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding British Journal of Obstetrics and Gynaecology 1981a 88 434 442 7225303
  68. Smith SK Abel MH Kelly RW Baird DT A role for prostacyclin (PGi2) in excessive menstrual bleeding Lancet 1981b 1 522 524 6111633
  69. Sonoshita M Takaku K Sasaki N Sugimoto Y Ushikubi F Narumiya S Oshima M Taketo MM Acceleration of intestinal polyposis through prostaglandin receptor EP2 in APC delta 714 knockout mice Nature Medicine 2001 7 1048 1051 11533709
  70. Stirrat GM Choice of treatment for menorrhagia Lancet 1999 353 2175 2176 10392977
  71. Subbaramaiah K Zakim D Weksler BB Dannenberg AJ Inhibition of cyclooxygenase: a novel approach to cancer prevention Proceedings of the Society for Experimental Biology and Medicine 1997 216 201 210 9349689
  72. Sugimoto Y Negishi M Hayashi Y Namba T Honda A Watabe A Hirata M Narumiya S Ichikawa A Two isoforms of the EP3 receptor with different carboxyl-terminal domains: identical ligand binding properties and different coupling properties with Gi proteins Journal of Biological Chemistry 1993 268 2712 2718 8381413
  73. Sugimoto Y Segi E Tsuboi K Ichikawa A Narumiya S Female reproduction in mice lacking the prostaglandin F receptor. Roles of prostaglandin and oxytocin receptors in parturition Advances in Experimental Medicine and Biology 1998 449 317 321 10026819
  74. Tilley SL Audoly LP Hicks EH Kim HS Flannery PJ Coffman TM Koller BH Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor Journal of Clinical Investigation 1999 103 1539 1545 10359563 PMC408376
  75. Tong BJ Tan J Tajeda L Das SK Chapman JA DuBois RN Dey SK Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-δ in human endometrial adenocarcinoma Neoplasia 2000 2 483 490 11228540 PMC1508090
  76. Tsujii M DuBois RN Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 1995 83 493 501 8521479
  77. Tsujii M Kawano S DuBois RN Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential Proceedings National Academy of Sciences USA 1997 94 3336 3340 PMC20370 9096394
  78. Tsujii M Kawano S Tsuji S Sawaoka H Hori M DuBois RN Cyclooxygenase regulates angiogenesis induced by colon cancer cells Cell 1998 93 705 716 9630216
  79. Watanabe K Kawamori T Nakatsugi S Role of prostaglandin E receptor subtype EP1 in colon carcinogenesis Cancer Research 1999 59 5093 5096 10537280
  80. Watanabe K Kawamori T Nakatsugi S Inhibitory effect of a prostaglandin E receptor subtype EP1 selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice Cancer Letters 2000 156 57 61 10840160

Cited by

Sorted by citations

Authors
Sales, K. J., & Jabbour, H. N.
Affiliations
MRC Centre for Reproductive Health (GB)
Venue
Reproduction
Published
2003-11-01
Volume
126
Issue
5
Pages
559-567
ISSN
  • 1470-1626 (ISSN-L)
  • 1741-7899
OpenAlex
W2155438634
Cited by
177
References
3
Citations by year
2026: 5 · 2025: 4 · 2024: 10 · 2023: 4 · 2022: 5 · 2021: 9 · 2020: 9 · 2019: 5 · 2018: 7 · 2017: 8 · 2016: 8 · 2015: 5 · 2014: 11 · 2013: 6 · 2012: 13
FWCI
0.69
Type
journal article
Language
en
Open access
Locations
  • Reproduction (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
Keywords
cyclooxygenase, prostaglandins, endometrium, endometrial pathology, prostaglandin E2, prostaglandin F2alpha, endometriosis, menorrhagia, dysmenorrhea, endometrial cancer, menstruation, endometrial proliferation, angiogenesis, apoptosis, metastasis, immunosuppression, prostanoid receptors
MeSH terms
Endometriosis, Enzyme Activation, Female, Humans, Menstruation Disturbances, Prostaglandin-Endoperoxide Synthases, Prostaglandins, Receptors, Prostaglandin, Uterine Diseases, Signal Transduction, Endometrial Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review